TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. | J Immunol;187(5): 2453-63, 2011 Sep 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.

Borbulevych, Oleg Y; Santhanagopolan, Sujatha M; Hossain, Moushumi; Baker, Brian M.

Affiliation

Borbulevych OY; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.

J Immunol ; 187(5): 2453-63, 2011 Sep 01.

Article in En | MEDLINE | ID: mdl-21795600

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Genetic Therapy / MART-1 Antigen Limits: Animals / Humans Language: En Journal: J Immunol Year: 2011 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Genetic Therapy / MART-1 Antigen Limits: Animals / Humans Language: En Journal: J Immunol Year: 2011 Document type: Article Affiliation country: Country of publication: